ID   KCNH1_MOUSE             Reviewed;         989 AA.
AC   Q60603; Q32MR6; Q3USQ9;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2016, sequence version 2.
DT   07-APR-2021, entry version 190.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 1;
DE   AltName: Full=Ether-a-go-go potassium channel 1;
DE            Short=EAG channel 1;
DE            Short=EAG1;
DE            Short=m-eag;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv10.1;
GN   Name=Kcnh1; Synonyms=Eag;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8159766; DOI=10.1073/pnas.91.8.3438;
RA   Warmke J.W., Ganetzky B.;
RT   "A family of potassium channel genes related to eag in Drosophila and
RT   mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3438-3442(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAE24272.1};
RC   TISSUE=Corpora quadrigemina {ECO:0000312|EMBL:BAE24272.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ACTIVITY REGULATION, LACK OF CYCLIC NUCLEOTIDE BINDING, FUNCTION,
RP   SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=19671703; DOI=10.1074/jbc.m109.016337;
RA   Brelidze T.I., Carlson A.E., Zagotta W.N.;
RT   "Absence of direct cyclic nucleotide modulation of mEAG1 and hERG1 channels
RT   revealed with fluorescence and electrophysiological methods.";
RL   J. Biol. Chem. 284:27989-27997(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-974; SER-978 AND SER-981, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   INTERACTION WITH RABEP1.
RX   PubMed=22841712; DOI=10.1016/j.febslet.2012.07.055;
RA   Ninkovic M., Mitkovski M., Kohl T., Stuhmer W., Pardo L.A.;
RT   "Physical and functional interaction of KV10.1 with Rabaptin-5 impacts ion
RT   channel trafficking.";
RL   FEBS Lett. 586:3077-3084(2012).
RN   [8]
RP   DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=23424202; DOI=10.1093/hmg/ddt076;
RA   Ufartes R., Schneider T., Mortensen L.S., de Juan Romero C., Hentrich K.,
RA   Knoetgen H., Beilinson V., Moebius W., Tarabykin V., Alves F., Pardo L.A.,
RA   Rawlins J.N., Stuehmer W.;
RT   "Behavioural and functional characterization of Kv10.1 (Eag1) knockout
RT   mice.";
RL   Hum. Mol. Genet. 22:2247-2262(2013).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25556795; DOI=10.1113/jphysiol.2014.281600;
RA   Mortensen L.S., Schmidt H., Farsi Z., Barrantes-Freer A., Rubio M.E.,
RA   Ufartes R., Eilers J., Sakaba T., Stuehmer W., Pardo L.A.;
RT   "KV 10.1 opposes activity-dependent increase in Ca2+ influx into the
RT   presynaptic terminal of the parallel fibre-Purkinje cell synapse.";
RL   J. Physiol. (Lond.) 593:181-196(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 552-707, DOMAIN,
RP   CALMODULIN-BINDING REGION, AND MUTAGENESIS OF VAL-628; 697-LEU--TYR-699;
RP   TYR-699; 699-TYR--LEU-701 AND 705-ILE--PHE-707.
RX   PubMed=22732247; DOI=10.1016/j.jmb.2012.06.025;
RA   Marques-Carvalho M.J., Sahoo N., Muskett F.W., Vieira-Pires R.S.,
RA   Gabant G., Cadene M., Schonherr R., Morais-Cabral J.H.;
RT   "Structural, biochemical, and functional characterization of the cyclic
RT   nucleotide binding homology domain from the mouse EAG1 potassium channel.";
RL   J. Mol. Biol. 423:34-46(2012).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 6-136 AND 552-724, FUNCTION,
RP   SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF 7-ARG-ARG-8; ARG-57;
RP   GLU-627 AND ASP-642.
RX   PubMed=23975098; DOI=10.1038/nature12487;
RA   Haitin Y., Carlson A.E., Zagotta W.N.;
RT   "The structural mechanism of KCNH-channel regulation by the eag domain.";
RL   Nature 501:444-448(2013).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 28-137.
RX   PubMed=23555008; DOI=10.1371/journal.pone.0059265;
RA   Adaixo R., Harley C.A., Castro-Rodrigues A.F., Morais-Cabral J.H.;
RT   "Structural properties of PAS domains from the KCNH potassium channels.";
RL   PLoS ONE 8:E59265-E59265(2013).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 727-743 IN COMPLEX WITH CALM,
RP   MUTAGENESIS OF VAL-737; LEU-740 AND PHE-741, AND INTERACTION WITH CALM.
RX   PubMed=27618660; DOI=10.1016/j.str.2016.07.020;
RA   Marques-Carvalho M.J., Oppermann J., Munoz E., Fernandes A.S., Gabant G.,
RA   Cadene M., Heinemann S.H., Schoenherr R., Morais-Cabral J.H.;
RT   "Molecular insights into the mechanism of calmodulin inhibition of the EAG1
RT   potassium channel.";
RL   Structure 24:1742-1754(2016).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of a voltage-gated delayed
CC       rectifier potassium channel (PubMed:19671703, PubMed:23975098). Channel
CC       properties are modulated by subunit assembly. Mediates IK(NI) current
CC       in myoblasts. Involved in the regulation of cell proliferation and
CC       differentiation, in particular adipogenic and osteogenic
CC       differentiation in bone marrow-derived mesenchymal stem cells (MSCs)
CC       (By similarity). {ECO:0000250|UniProtKB:O95259,
CC       ECO:0000269|PubMed:19671703, ECO:0000269|PubMed:23975098}.
CC   -!- ACTIVITY REGULATION: Channel activity is inhibited by interaction with
CC       Ca(2+)-bound calmodulin. Interaction of a single pore-forming alpha
CC       subunit with a calmodulin chain is sufficient to promote channel
CC       closure (By similarity). Channel activity is not regulated by cyclic
CC       nucleotides (PubMed:19671703). Channel activity is inhibited by binding
CC       intracellular phosphatidylinositol-3,5-bisphosphate and
CC       phosphatidylinositol-4,5-bisphosphate (PIP2), but is not inhibited by
CC       phosphatidylinositol 4-phosphate (By similarity).
CC       {ECO:0000250|UniProtKB:O95259, ECO:0000269|PubMed:19671703}.
CC   -!- SUBUNIT: The potassium channel is composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with KCNH5/EAG2
CC       (By similarity). Interacts with ALG10B (By similarity). Interacts with
CC       RABEP1 (PubMed:22841712). Interacts (via C-terminus) with CTTN.
CC       Interacts (via C-terminal cytoplasmic region) with Ca(2+)-bound
CC       calmodulin (PubMed:27618660). {ECO:0000250|UniProtKB:O95259,
CC       ECO:0000269|PubMed:22841712, ECO:0000269|PubMed:27618660}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19671703,
CC       ECO:0000269|PubMed:23975098}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O95259}. Nucleus inner membrane
CC       {ECO:0000250|UniProtKB:O95259}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O95259}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q63472}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q63472}. Cell junction, synapse, presynaptic
CC       cell membrane {ECO:0000269|PubMed:25556795}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q63472}. Cell junction, synapse, postsynaptic
CC       density membrane {ECO:0000250|UniProtKB:Q63472}. Early endosome
CC       membrane {ECO:0000250|UniProtKB:O95259}. Note=Perinuclear KCNH1 is
CC       located to NPC-free islands. {ECO:0000250|UniProtKB:O95259}.
CC   -!- TISSUE SPECIFICITY: Detected in brain (at protein level)
CC       (PubMed:23424202, PubMed:25556795). Highly expressed in olfactory bulb.
CC       Detected in brain cortex, hippocampus, brain stem, striatum, thalamus,
CC       hypothalamus and spinal cord (PubMed:23424202).
CC       {ECO:0000269|PubMed:23424202, ECO:0000269|PubMed:25556795}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at every
CC       third position. {ECO:0000250|UniProtKB:Q63472}.
CC   -!- DOMAIN: The C-terminal region interacts with the cyclic nucleotide-
CC       binding domain and contributes to regulate channel gating.
CC       {ECO:0000269|PubMed:23975098, ECO:0000305|PubMed:22732247}.
CC   -!- DOMAIN: The PAS and PAC domain interact with the cyclic nucleotide-
CC       binding domain and contribute to the regulation of channel gating
CC       (PubMed:23975098). Calmodulin binding clamps together the PAS and PAC
CC       domain with the cyclic nucleotide-binding domain from a neighboring
CC       subunit and causes a conformation change that leads to channel closure.
CC       {ECO:0000250|UniProtKB:Q63472, ECO:0000269|PubMed:23975098}.
CC   -!- DOMAIN: The cyclic nucleotide-binding domain lacks residues that are
CC       essential for nucleotide-binding and cannot bind cyclic nucleotides
CC       (PubMed:19671703). Instead, residues from the C-terminal domain (the
CC       so-called intrinsic ligand) bind in the cavity that would be expected
CC       to bind cyclic nucleotides. Interaction with the C-terminal region
CC       hinders interaction with CALM and reduces the affinity for CALM.
CC       {ECO:0000269|PubMed:19671703, ECO:0000269|PubMed:22732247,
CC       ECO:0000269|PubMed:23975098}.
CC   -!- PTM: Channel activity is regulated via tyrosine
CC       phosphorylation/dephosphorylation by SRC and PTPN6.
CC       {ECO:0000250|UniProtKB:O95259}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype. Mice are viable and
CC       fertile, and have normal brain morphology. Likewise, there is no change
CC       in the electrophysiological properties of cerebellar Purkinje cells and
CC       in the shape and frequency of action potentials.
CC       {ECO:0000269|PubMed:23424202}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv10.1/KCNH1 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U04294; AAA62474.1; -; mRNA.
DR   EMBL; AK140193; BAE24272.1; -; mRNA.
DR   EMBL; CH466555; EDL12967.1; -; Genomic_DNA.
DR   EMBL; BC109013; AAI09014.1; -; mRNA.
DR   CCDS; CCDS15627.1; -.
DR   PIR; I48912; I48912.
DR   RefSeq; NP_034730.1; NM_010600.3.
DR   PDB; 4F8A; X-ray; 2.20 A; A=552-707.
DR   PDB; 4HOI; X-ray; 1.85 A; A/B/C/D=28-137.
DR   PDB; 4LLO; X-ray; 2.00 A; A/C/E/G=552-724, B/D/F/H=6-136.
DR   PDB; 5HIT; X-ray; 2.85 A; B=727-743.
DR   PDBsum; 4F8A; -.
DR   PDBsum; 4HOI; -.
DR   PDBsum; 4LLO; -.
DR   PDBsum; 5HIT; -.
DR   SMR; Q60603; -.
DR   BioGRID; 200892; 4.
DR   IntAct; Q60603; 1.
DR   MINT; Q60603; -.
DR   STRING; 10090.ENSMUSP00000077563; -.
DR   GlyGen; Q60603; 2 sites.
DR   iPTMnet; Q60603; -.
DR   PhosphoSitePlus; Q60603; -.
DR   PaxDb; Q60603; -.
DR   PRIDE; Q60603; -.
DR   ProteomicsDB; 269200; -.
DR   GeneID; 16510; -.
DR   KEGG; mmu:16510; -.
DR   UCSC; uc007edo.2; mouse.
DR   CTD; 3756; -.
DR   MGI; MGI:1341721; Kcnh1.
DR   eggNOG; KOG0501; Eukaryota.
DR   InParanoid; Q60603; -.
DR   OrthoDB; 464006at2759; -.
DR   PhylomeDB; Q60603; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-MMU-1296072; Voltage gated Potassium channels.
DR   BioGRID-ORCS; 16510; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Kcnh1; mouse.
DR   PRO; PR:Q60603; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q60603; protein.
DR   Bgee; ENSMUSG00000058248; Expressed in secondary oocyte and 141 other tissues.
DR   Genevisible; Q60603; MM.
DR   GO; GO:0030673; C:axolemma; ISO:MGI.
DR   GO; GO:0030424; C:axon; ISO:MGI.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0031901; C:early endosome membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; ISO:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0005637; C:nuclear inner membrane; ISO:MGI.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0098839; C:postsynaptic density membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0034705; C:potassium channel complex; ISO:MGI.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:MGI.
DR   GO; GO:0045202; C:synapse; ISO:MGI.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; ISO:MGI.
DR   GO; GO:0005516; F:calmodulin binding; ISO:MGI.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0044325; F:ion channel binding; ISO:MGI.
DR   GO; GO:1902936; F:phosphatidylinositol bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0099508; F:voltage-gated ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; ISO:MGI.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0099509; P:regulation of presynaptic cytosolic calcium ion concentration; IDA:SynGO.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IDA:SynGO.
DR   GO; GO:0001964; P:startle response; ISO:MGI.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR030170; EAG1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003949; K_chnl_volt-dep_EAG.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF530; PTHR10217:SF530; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01464; EAGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calmodulin-binding; Cell junction; Cell membrane;
KW   Cell projection; Endosome; Glycoprotein; Ion channel; Ion transport;
KW   Lipid-binding; Membrane; Nucleus; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..989
FT                   /note="Potassium voltage-gated channel subfamily H member
FT                   1"
FT                   /id="PRO_0000053995"
FT   TOPO_DOM        1..220
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TRANSMEM        221..241
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TOPO_DOM        242..248
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TRANSMEM        249..269
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TOPO_DOM        270..290
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TRANSMEM        291..309
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TOPO_DOM        310..345
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TRANSMEM        346..368
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TOPO_DOM        369..377
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TRANSMEM        378..399
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TOPO_DOM        400..448
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   INTRAMEM        449..470
FT                   /note="Pore-forming; Name=Segment H5"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TOPO_DOM        471..477
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TRANSMEM        478..498
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   TOPO_DOM        499..989
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   DOMAIN          14..94
FT                   /note="PAS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          93..145
FT                   /note="PAC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00141"
FT   REGION          151..162
FT                   /note="Required for phosphatidylinositol bisphosphate
FT                   binding"
FT                   /evidence="ECO:0000250|UniProtKB:O95259"
FT   REGION          673..770
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:22732247,
FT                   ECO:0000269|PubMed:27618660"
FT   REGION          699..701
FT                   /note="Interaction with cyclic nucleotide-binding pocket"
FT                   /evidence="ECO:0000269|PubMed:22732247"
FT   REGION          924..964
FT                   /note="CAD (involved in subunit assembly)"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   MOTIF           463..468
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:Q63472"
FT   MOD_RES         974
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         978
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         981
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CARBOHYD        415
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        433
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         7..8
FT                   /note="RR->AA,EE: Strongly shifts the voltage-dependent
FT                   channel activation to more depolarized membrane
FT                   potentials."
FT                   /evidence="ECO:0000269|PubMed:23975098"
FT   MUTAGEN         57
FT                   /note="R->D: Decreases the rate of channel opening. No
FT                   effect; when associated with R-642."
FT                   /evidence="ECO:0000269|PubMed:23975098"
FT   MUTAGEN         627
FT                   /note="E->A,R: Strongly shifts the voltage-dependent
FT                   channel activation to much more depolarized membrane
FT                   potentials."
FT                   /evidence="ECO:0000269|PubMed:23975098"
FT   MUTAGEN         628
FT                   /note="V->A,L: Mildly increases the affinity for CALM."
FT                   /evidence="ECO:0000269|PubMed:22732247"
FT   MUTAGEN         642
FT                   /note="D->R: Decreases the rate of channel opening. No
FT                   effect; when associated with D-57."
FT                   /evidence="ECO:0000269|PubMed:23975098"
FT   MUTAGEN         697..699
FT                   /note="LTY->ATA: Increases the affinity for CALM."
FT                   /evidence="ECO:0000269|PubMed:22732247"
FT   MUTAGEN         699..701
FT                   /note="YNL->ANA: Increases the affinity for CALM."
FT                   /evidence="ECO:0000269|PubMed:22732247"
FT   MUTAGEN         699
FT                   /note="Y->W: Mildly increases the affinity for CALM."
FT                   /evidence="ECO:0000269|PubMed:22732247"
FT   MUTAGEN         705..707
FT                   /note="IVF->AAA: Decreases the affinity for CALM."
FT                   /evidence="ECO:0000269|PubMed:22732247"
FT   MUTAGEN         737
FT                   /note="V->A: No effect on affinity for CALM; when
FT                   associated with A-740."
FT                   /evidence="ECO:0000269|PubMed:27618660"
FT   MUTAGEN         737
FT                   /note="V->S: Decreases affinity for CALM 230-fold; when
FT                   associated with S-740."
FT                   /evidence="ECO:0000269|PubMed:27618660"
FT   MUTAGEN         740
FT                   /note="L->A: No effect on affinity for CALM; when
FT                   associated with A-737."
FT                   /evidence="ECO:0000269|PubMed:27618660"
FT   MUTAGEN         740
FT                   /note="L->S: Decreases affinity for CALM 230-fold; when
FT                   associated with S-737."
FT                   /evidence="ECO:0000269|PubMed:27618660"
FT   MUTAGEN         741
FT                   /note="F->S: Decreases affinity for CALM about 30-fold."
FT                   /evidence="ECO:0000269|PubMed:27618660"
FT   CONFLICT        808
FT                   /note="V -> M (in Ref. 1; AAA62474 and 2; BAE24272)"
FT   HELIX           17..22
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          29..34
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   STRAND          41..45
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   HELIX           47..53
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   HELIX           57..60
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   HELIX           68..70
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   HELIX           77..88
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   STRAND          93..100
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   STRAND          106..117
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   STRAND          123..132
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   TURN            134..136
FT                   /evidence="ECO:0007744|PDB:4HOI"
FT   STRAND          555..559
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           565..571
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           573..576
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           580..582
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           587..596
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          598..602
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          607..609
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          613..615
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          617..624
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          626..630
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          633..638
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          643..645
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   TURN            647..651
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          658..673
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           674..683
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           685..694
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   STRAND          698..700
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           710..718
FT                   /evidence="ECO:0007744|PDB:4LLO"
FT   HELIX           736..741
FT                   /evidence="ECO:0007744|PDB:5HIT"
SQ   SEQUENCE   989 AA;  111282 MW;  AEC4C730E253DDC1 CRC64;
     MTMAGGRRGL VAPQNTFLEN IVRRSNDTNF VLGNAQIVDW PIVYSNDGFC KLSGYHRAEV
     MQKSSACSFM YGELTDKDTV EKVRQTFENY EMNSFEILMY KKNRTPVWFF VKIAPIRNEQ
     DKVVLFLCTF SDITAFKQPI EDDSCKGWGK FARLTRALTS SRGVLQQLAP SVQKGENVHK
     HSRLAEVLQL GSDILPQYKQ EAPKTPPHII LHYCVFKTTW DWIILILTFY TAILVPYNVS
     FKTRQNNVAW LVVDSIVDVI FLVDIVLNFH TTFVGPAGEV ISDPKLIRMN YLKTWFVIDL
     LSCLPYDVIN AFENVDEVSA FMGDPGKIGF ADQIPPPLEG RESQGISSLF SSLKVVRLLR
     LGRVARKLDH YIEYGAAVLV LLVCVFGLAA HWMACIWYSI GDYEIFDEDT KTIRNNSWLY
     QLALDIGTPY QFNGSGSGKW EGGPSKNSVY ISSLYFTMTS LTSVGFGNIA PSTDIEKIFA
     VAIMMIGSLL YATIFGNVTT IFQQMYANTN RYHEMLNSVR DFLKLYQVPK GLSERVMDYI
     VSTWSMSRGI DTEKVLQICP KDMRADICVH LNRKVFKEHP AFRLASDGCL RALAMEFQTV
     HCAPGDLIYH AGESVDSLCF VVSGSLEVIQ DDEVVAILGK GDVFGDVFWK EATLAQSCAN
     VRALTYCDLH VIKRDALQKV LEFYTAFSHS FSRNLILTYN LRKRIVFRKI SDVKREEEER
     MKRKNEAPLI LPPDHPVRRL FQRFRQQKEA RLAAERGGRD LDDLDVEKGN ALTDHTSANH
     SLVKASVVTV RESPATPVSF QAATTSTVSD HAKLHAPGSE CLGPKAVSCD PAKRKGWARF
     KDACGKGEDW NKVSKAESME TLPERTKAPG EATLKKTDSC DSGITKSDLR LDNVGETRSP
     QDRSPILAEV KHSFYPIPEQ TLQATVLEVK YELKEDIKAL NAKMTSIEKQ LSEILRILMS
     RGSAQSPQET GEISRPQSPE SDRDIFGAS
//
